Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Hengstman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|May 5, 2001
Anti-Jo-1 positive inclusion body myositis with a marked and sustained clinical improvement after oral prednisoneG J Hengstman, H J Ter Laak, B G van Engelen, et al.
Current Opinion in Rheumatology|November 8, 2001
Myositis-specific autoantibodies: overview and recent developmentsG J Hengstman, B G van Engelen, W T Vree Egberts, et al.
Journal of Neurology|January 11, 2001
Familial inclusion body myositis with histologically confirmed sensorimotor axonal neuropathyG J Hengstman, B G van Engelen, H J ter Laak, et al.
Annals of the Rheumatic Diseases|February 9, 2000
The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradientG J Hengstman, W J van Venrooij, J Vencovsky, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 20, 2003
[The anti-synthetase syndrome: muscle disease and multisystem disorder at the same time]G J Hengstman, W J van Venrooij, F H van den Hoogen, et al.
Neurology|June 14, 2000
Myositis during long-term interferon-alpha treatmentG J Hengstman, O J Vogels, H J ter Laak, et al.
Annals of Neurology|September 28, 1998
Presence of the anti-Jo-1 autoantibody excludes inclusion body myositisG J Hengstman, B G van Engelen, U A Badrising, et al.
Annals of the Rheumatic Diseases|January 13, 2001
Autoantibody profiles in the sera of European patients with myositisR Brouwer, G J Hengstman, W Vree Egberts, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Neurology, Neurosurgery, and Psychiatry|May 5, 2001
Anti-Jo-1 positive inclusion body myositis with a marked and sustained clinical improvement after oral prednisoneG J Hengstman, H J Ter Laak, B G van Engelen, et al.
Current Opinion in Rheumatology|November 8, 2001
Myositis-specific autoantibodies: overview and recent developmentsG J Hengstman, B G van Engelen, W T Vree Egberts, et al.
Journal of Neurology|January 11, 2001
Familial inclusion body myositis with histologically confirmed sensorimotor axonal neuropathyG J Hengstman, B G van Engelen, H J ter Laak, et al.
Annals of the Rheumatic Diseases|February 9, 2000
The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradientG J Hengstman, W J van Venrooij, J Vencovsky, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 20, 2003
[The anti-synthetase syndrome: muscle disease and multisystem disorder at the same time]G J Hengstman, W J van Venrooij, F H van den Hoogen, et al.
Neurology|June 14, 2000
Myositis during long-term interferon-alpha treatmentG J Hengstman, O J Vogels, H J ter Laak, et al.
Annals of Neurology|September 28, 1998
Presence of the anti-Jo-1 autoantibody excludes inclusion body myositisG J Hengstman, B G van Engelen, U A Badrising, et al.
Annals of the Rheumatic Diseases|January 13, 2001
Autoantibody profiles in the sera of European patients with myositisR Brouwer, G J Hengstman, W Vree Egberts, et al.
Pageof 1